semaglutide cardiovascular trial news A 2025 Lancet analysis of the SELECT concluded that reduced major adverse events by 20% in adults with overweight or obesity, regardless of how much weight patients actually lost Updates in Medicine | Not

As of July 2025, the FDA says its received 605 reports of adverse effects related to compounded semaglutides and 545 reports related to compounded tirzepatides

Dual Receptor Agonism The dual agonism of GIP and GLP-1 receptors by tirzepatide contributes to its powerful effects

Lower costs through TrumpRX may allow more people to access FDA-approved, safe GLP-1 medications, reducing reliance on compounded alternatives, which can carry legal and safety risks

When selecting a probiotic, patients should look for products that specify the strain designation (not merely the species), provide colony-forming unit (CFU) counts (typically 110 billion CFUs per dose), and demonstrate stability through appropriate packaging and storage conditions as indicated on the product label

Generally safe when prescribed by a doctor and monitored regularly